甲状腺機能検査市場：セグメント別規模、シェア、法規制、償還、2036年までの予測

甲状腺疾患は、甲状腺の構造的または機能的な異常によって引き起こされる傾向があり、ヨウ素欠乏地域またはヨウ素過剰地域での生活、および/またはグレーブ病や橋本病のような自己免疫疾患から生じることが多いです。さらに、甲状腺疾患の他の原因としては、視床下部または下垂体の障害、卵巣ストルマ、薬物誘発反応、甲状腺がんなどがあります。

甲状腺機能検査（TFT）は、甲状腺の機能を評価するために行われ、主に甲状腺機能低下症と甲状腺機能亢進症の検査に用いられます。TFTは一般的に、甲状腺ホルモン値の異常が疑われる場合に処方されます。体内の甲状腺ホルモンのレベルに異常があると、甲状腺機能亢進症（甲状腺ホルモンのレベルが高い）または甲状腺機能低下症（甲状腺ホルモンのレベルが低い）のどちらかが起こります。甲状腺機能の評価は、甲状腺および甲状腺関連ホルモンであるサイロキシン（T）、トリヨードサイロニン（T）、甲状腺刺激ホルモン（TSH）の濃度を測定することによって行うことができます。TSH検査、遊離サイロキシン（FT4）検査、総サイロキシン（TT4）検査、遊離トリヨードサイロニン（FT3）検査、総トリヨードサイロニン（TT3）検査、その他の甲状腺機能検査は、甲状腺機能を調べるために主に処方される定量検査です。TFTは、甲状腺機能亢進症と甲状腺機能低下症の診断とモニタリングの両方に処方されます。

当レポートは、世界の甲状腺機能検査市場について詳細に考察し、市場における競合情勢、SWOT分析、2036年までの市場予測、地域、国別の動向などを提供しています。

目次

現在上市されている甲状腺機能検査と競合情勢

• 主要な業界動向の洞察
• 甲状腺機能検査のセグメント別総市場収益と2015年～2036年の市場展望
• 件数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 甲状腺機能検査市場のSWOT分析
• 甲状腺機能検査市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

Thyroid Function Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Thyroid disease tends to be caused by structural or functional anomalies in the thyroid gland, which often result from living in iodine-deficient or iodine-excess areas and/or from autoimmune diseases such as Grave's disease and Hashimoto's disease. Additionally, other causes of thyroid disease include hypothalamus or pituitary disorders, struma ovarii, drug-induced responses, and thyroid cancer.

Thyroid Function Tests (TFTs) are performed to evaluate the function of the thyroid gland, principally in the investigation of hypothyroidism and hyperthyroidism. TFTs are generally prescribed when a patient is suspected of abnormal level of thyroid hormones. Abnormal levels of thyroid hormones in the body can cause either hyperthyroidism (high level of thyroid hormones) or hypothyroidism (low level of thyroid hormones). Evaluation of thyroid function can be done by determining the concentration of thyroid and thyroid-related hormones which are thyroxine (T), triiodothyronine (T), and thyroid stimulating hormone (TSH). TSH test, Free Thyroxine (FT4) Tests, Total Thyroxine (TT4) Tests, Free Triiodothyronine (FT3) Tests, Total Triiodothyronine (TT3) Tests, and Other Thyroid Function tests are majorly prescribed quantitative tests for accessing thyroid function. TFTs are prescribed for both the diagnosis and monitoring of hyperthyroidism and hypothyroidism.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Thyroid Function Tests and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Thyroid Function Tests market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Thyroid Function Tests market.
• Competitive dynamics insights and trends provided for Thyroid Function Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Beckman Coulter Inc, Roche Diagnostics International Ltd, Siemens Healthineers AG, Abbott Laboratories, Ortho-Clinical Diagnostics Holdings Plc, Inova Diagnostics Inc and others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Thyroid function tests marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Thyroid function tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Thyroid function tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Thyroid function tests market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.